Terek, DemetKayikcioglu, MeralKultursay, HakanErgenoglu, MeteYalaz, MehmetMusayev, OktayMogulkoc, NesrinGunusen, IlkbenAkisu, MeteKultursay, Nilgun2019-10-272019-10-2720131735-19951735-7136https://hdl.handle.net/11454/47073This is the case report of a pregnant woman who refused pregnancy termination when diagnosed with pulmonary arterial hypertension (PAH) functional class 2-3 at the 24th week of gestation and of her newborn. A pregnant woman with PAH functional class 2-3 was treated with inhaled prostacyclin analog ( iloprost), oral sildenafil, oxygen, and low molecular weight heparin. She delivered at 32nd week by Cesarean section. The infant required oxygen up to 36th week postconceptional age and had a short steroid treatment. The mother needed close cardiovascular monitorization, intensive oxygen and pulmonary vasodilator therapy for 2 months and was discharged with oxygen and oral iloprost treatment. A multidisciplinary approach together with pulmonary vasodilator therapy may be succesful in such a high-risk pregnant woman.eninfo:eu-repo/semantics/closedAccessIloprostnewbornpregnancypulmonary hypertensionsildenafilsurvivaltherapyArticle1817376WOS:00031786070001623900530N/A